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Introduction K-selective ion channel proteins form the largest and most diverse class of ion channels. Most of these channels are composed of fou r identical subunits assembled to provide a narrow Kselective pore and the crystal structures of several of these have been solved (Doyle et al., 1998; Jiang et al., 2002; Long et al., 2005) . BK (or maxi-K) channels are unique members of this very large class in that they are activated by both membrane voltage and by a ligand: Ca 2+ . A t negative potentials and at low Ca 2+ levels these channels are closed. Depolarization, sensed by positively charged amino acid residues in the 4 th membrane spanning (S4) domain of each Mol # 75234 their prominent physiological roles BK channels have been actively targeted for the development of therapeutic compounds (e. g. Garcia et al., 1995; Garcia et al., 2007; Gribkoff et al., 2001; Jensen et al., 2003; Marx and Zakharov, 2009; Nardi and Olesen, 2008) . One class of potentially therapeutic drugs increases the activation of BK-even at relatively negative membrane voltages.
Many such compounds have been identified and most of th ese act by producing a hyperpolarizing shift of channel activation (reviewed by Gribkoff et al., 1997) . On e class of such activators is the benzimidazalones exemplified by NS-1619 and its structural analogs (Strobaek et al., 1996) . A very powerful addition to the list of BK modulating compounds has recently been identified: m allotoxin (rottlerin), a liphophilic product isolated from a powder covering the capsules of the Mallotus phillippinensis tree. Concentrations of mallotoxin (MTX) in the μM range shift BK channel activation by more than 100 mV (Zakharov et al., 2005) .
These large effects of MTX occur on native BK channels in human smooth muscle cells as well as heterologously expressed channels. Both the benzimidazalones and MTX have been proposed for therapeutic uses (Marx and Zakharov, 2009; Teuber et al., 2003 ).
As noted above, BK channels are involved in fluid and electrolyte secretion in such tissues as salivary glands. Defects in fluid secretion underlie several pathological conditions including oral pain, increased dental caries, and infections by opportunistic microorganisms such as Candida albicans. It is possible that activation of K channels in these cells would promote fluid secretion and so BK-activators could have therapeutic value in salivary gland pathologies. W e tested MTX on BK channels in mouse parotid acinar cells and, contrary to the findings described above, found a negligible effect of t his compound on the voltage dependence of s teady-state activation. We investigated the reasons for the lack of effectiveness of this activator on parotid Mol # 75234 6 BK channels and found that a recently identified accessory protein, LRRC26 (Yan and Aldrich, 2010) caused BK channels to lose their sensitivity to the gating shift of MTX. We tested the specificity of the LRRC26 accessory protein by examining the action of another BK channel activator, NS1619, on BK channels with and without the protein. We found a minimal effect of the accessory protein on the effectiveness of NS1619. Thus, the LRRC26 accessory protein can selectively control the sensitivity of BK channels to channel modulators. channels will not interfere with our measurements of BK channel currents from the parotid cells.
The lack of IK1 currents in our measurements can be seen by the absence of a significant time independent component in the raw currents records of Fig. 1 -a hallmark of IK1 channels (e.g. et al., 1997) . Mallotoxin (rottlerin) and NS1619 were purchased from Sigma, stored at -20 C° in aliquots in DMSO and diluted to produce the final working concentrations.
Ishii

Electrophysiological recordings
Whole cell currents were acquired at room temperature using Axopatch 200B amplifier and Digidata 1320A digitizer (Axon Instruments, Foster City, CA) at 50 kHz sampling rate and filtered online at 5 kHz using a lowpass Bessel filter. P atch pipettes were made from quartz 
Data analysis
The voltage dependence of channel activation was estimated from steady-state conductance as:
where V K is the K + equilibrium potential. T hese conductance-voltage relations were fit by the Boltzmann equation:
where z is the effective valence that controls the voltage sensitivity (steepness) of activation, V h is the voltage at hal f activation, and F, R and T have their usual thermodynamic meanings. is quite similar to the voltage at which the activation time constant achieves its maximum value (Horrigan and Aldrich, 2002) so, for our H-A analysis of expressed parSlo BK channels we constrained V J to be within 20 mV of this value (Fig. 2B ). The z parameters were constrained to be between 0 a nd 2. Parameter seed values for the fitting algorithm were those from our previous similar analysis (Romanenko et al., 2010) . F or the analysis of t he MTX-treated channels ( Fig. 7B) , the z parameters were fixed at the values from the fit to the control data and the VJ value was constrained to be within 20 mV of the voltage at which the activation time constant achieved its maximum value (100 mV, see Fig. 2B ).
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MTX action on BK channels in parotid acinar cells
As illustrated in The very small effect of MTX on the voltage dependence of parotid BK channel activation was quite surprising since a 10-fold lower concentration (0.5 μM) has been reported to produce a 100 mV shift of heterologously expressed BK channels and a dramatic increase in activity of BK channels in h uman smooth muscle cells (Zakharov et al., 2005) . T his discrepancy could potentially be the result of differences between the parotid BK channel isoform (Nehrke et al.,
This article has not been copyedited and formatted. The final version may differ from this version. Nehrke et al., 2003) . Nevertheless, to more rigorously test for a possible isoform-specific action,
we assessed the effect of MTX on heterologously expressed parotid BK (parSlo) channels and an example of the results is illustrated in Fig. 2 .
MTX on heterologously expressed parSlo BK channels
The insets of Fig can be activated at relatively negative voltages. A few other cell types share this property including mammalian inner hair cells (Thurm et al., 2005) and prostate cancer cells (Gessner et al., 2005) . It was recently shown that a BK channel auxiliary protein (LRRC26) is responsible Mol # 75234
for the hyperpolarized activation of the BK channels in these prostate cancer cells (Yan and Aldrich, 2010) . In addition to the prostate LRRC26 is also highly expressed in normal salivary glands and at low levels in colon, pancreas, and intestine (Egland et al., 2006) . In addition, the Fig. 3A show that parSlo channels associated with the LRRC26 channel were activated at potentials about 140 mV more negative than channels formed by only the parSlo subunits.
There was also an increase in the steepness of the voltage dependence of steady-state activation as indicated by an in crease in t he z parameter. T he effects of LRRC26 expression on parSlo steady-state activation are summarized in Table 1 Mol # 75234
MTX action on ParSlo + LRRC26 BK channels
The results illustrated in Fig. 3 show that, as predicted, co-expression of LRRC26 resulted in BK channels with gating properties much more like the channels in native parotid cells than channels consisting of only the parSlo subunit. W e next tested our hypothesis that the very different effects of MTX on native parotid and expressed parSlo BK channels could be accounted for by the LRRC26 protein. Thus, we examined the actions of MTX on parSlo + LRRC26 channels and the results are illustrated in Fig. 4 . (Fig. 2B ), MTX produced a much smaller shift along with a decrease in the peak time constant of parSlo + LRRC26 BK channels.
In summary, co-expression of LRRC26 with parSlo produced BK channels with intrinsic gating properties and sensitivity to MTX that reflected the properties of the channels in native parotid cells.
This article has not been copyedited and formatted. The final version may differ from this version. Mol # 75234 MTX action on heterologously expressed parSlo BK channels with high internal Ca
2+
As shown in Figs. 1 and 4, MTX had a much smaller effect on steady-state activation of native and expressed parSlo + LRRC26 BK channels than on channels formed only of parSlo subunits (Fig. 2) . The native and parSlo + LRRC26 channels have a much more hyperpolarized activation range than parSlo-only channels. T hus, it is possible that the inability of MTX to produce a hyperpolarizing shift of the activation of these channels was due to their already rather negative activation range. We tested this idea by examining MTX action on expressed parSlo BK channels whose activation was shifted to more hyperpolarized potentials by inclusion of Ca 2+ in the intracellular solution (Fig. 5 ).
Fig . 5A shows that 10 μM internal Ca 2+ caused expressed parSlo BK channels to activate at potentials even more negative than native BK channels or channels co-expressed with LRRC26.
Nevertheless, MTX still produced a strong shift of channel activation to even more negative potentials. We found a mean V h value of 35 ± 2 mV (N = 10) in the absence of MTX and mean value of -3 ± 3 mV in the presence of 5 μM MTX. Thus, MTX was able to produce a 38 mV hyperpolarizing shift even of BK channels with an already hyperpolarized activation range-not as large as the 70 mV shift observed in zero Ca 2+ but considerably larger than the shift of native BK channels or expressed parSlo + LRRC26 channels.
It should be noted that this finding complements the results from an analogous set of experiments by (Zakharov et al., 2005) . Those authors measured the ability of intracellular Ca 2+ to shift BK channel activation in the presence of MTX whereas we tested the efficacy of MTX in the presence of elevated Ca 2+ . Their study was with cell-free, inside out patches whereas our results
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were obtained from intact cells. Nevertheless, we came to the same conclusion that the shifts produced by intracellular Ca 2+ and MTX were independent of one another. However, the solid line, which provides a reasonable description of the MTX data, is the result of fitting Eq. 1 to the data but with the constraints that the effective valance values (z a and z b ) maintain their control values; that is, a good fit was obtained by allowing only a simple shift of the voltage dependence.
The LRRC26 accessory protein and other BK channel activators
As noted in Introduction, there are several classes of BK channel activator compounds and a relevant question for this study was if the LRRC26 interfered with BK activators other than MTX. Be nzimidazalones, like NS1619, are structurally very different from MTX but both produce large hyperpolarizing shifts in BK channel activation. Gessner et al., (2005) found that NS1619 caused a substantial shift of activation of BK channels in the LNCap prostate cell line.
These channels contain the LRRC26 protein suggesting that its ability to interfere with BK activators may not be universal. To specifically examine the role of LRRC26 on BK channel activation by NS1619 we tested the effectiveness of NS1619 on heterologously expressed ParSlo shows that a s omewhat smaller but s till large shift is produced in channels with the LRRC26 protein.
In the example shown the V h value for activation was 54 mV and 4 mV in the absence and presence of NS1619, respectively. In a to tal of 6 s imilar experiments the mean V h value without NS1619 was 51 ± 2.9 mV, similar to values described above and the mean hyperpolarizing shift produced by 50 μM NS1619 was 47 ± 3.2 mV. That is, the NS1619-induced shift of BK channel activation was reduced by only 23% in the presence of the LRRC26 channel. In contrast, under similar conditions, the LRRC26 protein inhibited the MTX-induced gating shift by 76%.
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Discussion
Several new findings have resulted from this study. In contrast to previous findings on smooth muscle BK channels, mallotoxin had very little effect on the voltage dependence of activation of BK channels in native parotid acinar cells. However, MTX was not entirely without effect as it produced a two-fold increase in the speed of parotid BK channel activation. We showed that the limited action of MTX on the voltage dependence of BK channel activation in parotid cells was likely due to the existence of a BK channel accessory protein, LRRC26, which is expressed in salivary glands including parotid (Egland et al., 2006; Gonzalez-Begne et al., 2009) . C oexpression of the parotid BK isoform (parSlo) with LRRC26 produced channels that mimicked many of the properties of those in t he native cells including: (1) a hyperpolarized activation range; (2) resistance to MTX modification of steady-state activation; and (3) a speeding of gating kinetics by MTX. We suggest that the relatively small differences between native parotid and parSlo + LRRC26 BK channels may be due to an incomplete stoichiometry in the heterologous expression system. Finally, we showed that while the LRRC26 protein inhibited the gating shift produced by MTX, it had a minimal effect on the gating shift produced by NS1619. This result shows that the LRRC26 protein has a selective effect on BK channel pharmacology.
One possible mechanism for the inability of MTX to shift the voltage dependence of BK channels formed with the LRRC26 protein is that the accessory protein prevents binding of MTX to the channel complex. This does not seem to be the case since even though MTX did not produce a s ignificant activation shift of BK + LRRC26 channels it d id produce a s ubstantial increase in the speed of activation of this BK channel complex (Figs. 1 a nd 4) . The fact that MTX increased the kinetics of BK + LRRC26 channels but had no effect on the kinetics of BK This article has not been copyedited and formatted. The final version may differ from this version.
Mol # 75234 channels without LRRC26 (Fig. 2) suggests another mechanism in which MTX displaces the LRRC26 protein reversing the slowing effect by the accessory protein and r eplacing the shift produced by LRRC26 by its own gating shift. The data in Figs 1 and 3 show that this idea is quantitatively reasonable. The peak time constants of parotid and parSlo + LRRC26 channels were quite similar and MTX caused the time constant of parSlo + LRRC26 channels to approach that of parSlo-only channels. Thus, the simple idea that MTX displaces the LRRC26 protein is quantitatively consistent with both the increase in activation kinetics and the minimal effect on the voltage dependence of activation of BK channels with the LRRC26 protein.
The functional basis for MTX and LRRC26 action
More insight into the mechanism by which MTX and the LRRC26 protein compete could come from an un derstanding of the mechanisms by which they produce their large hyperpolarizing The overall channel open probability for this scheme is given by:
Mol # 75234 well-described by the H-A model with a set of parameters similar to those that have been reported previously. They went on to show that the data from channels with the LRRC26 protein could be accounted for if the allosteric coupling parameter D was greatly increased. We did a similar analysis of data from heterologously expressed parSlo channels in the absence and presence of MTX and the results are illustrated in Fig. 7 .
The open circles in Fig. 7 Thus, the MTX data could not be described by a cha nge in a ny single aspect of BK channel gating. Indeed we found that the only way to accurately describe the action of MTX was to allow all three parameters to change. 
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Summary BK channels are valuable targets for therapeutic interventions and many compounds have been identified that modify BK channel gating. O ne such compound is mallotoxin (MTX) which produces a l arge increase in t he activation of smooth muscle BK channels. In contrast, we showed that MTX had only a minor effect on steady-state activation of BK channels in parotid acinar cells. We hypothesized that this was due to the presence in parotid cells of LRRC26, a protein known to produce a hy perpolarizing shift of BK channel activation and one that is expressed in these cells. We confirmed this hypothesis by showing that MTX was only weakly effective on steady-state activation of parotid BK channel isoform co-expressed with the LRRC26. We showed that the action of the LRRC26 protein was selective: it strongly interfered with the hyperpolarizing shift produced by MTX but had a minimal effect on the hyperpolarizing activation shift produced by the benzimidazalone BK activator NS1619. We suggest that the ineffectiveness of the MTX on BK channels with the LRRC26 protein was the result of a competition between MTX and the LRRC26 protein for their action on the BK channel gating machinery. P resumably, the physical chemical properties of NS1619 allow it to act independently of the LRRC26 protein. Indeed, Zakharov et al., (2005) showed that MTX shifts BK channel activation even in the presence of NS1619. Our results highlight the fact that the screening of BK channel drugs needs to include consideration for BK accessory proteins like LRRC26 and that it may be possible to take advantage of this behavior to design tissue-specific BK channel modifying drugs. This article has not been copyedited and formatted. The final version may differ from this version. 
